On June 20th, Gelunhui reported that Jiangsu Hengrui Pharmaceuticals (600276.SH) announced the first repurchase of 370,000 shares of stock through centralized bidding transactions on June 20th, 2024. The repurchased shares accounted for 0.01% of the total share capital of the company. The highest transaction price was 40.77 yuan/share, the lowest was 40.58 yuan/share, and the total amount paid was 15,045,277 yuan (excluding transaction fees).
恒瑞医药(600276.SH)：首次回购37万股
Jiangsu Hengrui Pharmaceuticals (600276.SH) announced the buyback of 370,000 shares for the first time.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.